Nancy Zahniser Memorial Symposium: The Dopamine Transporter in Health and Disease
Sunday April 22, 2018
9:30 am
-
12:00 pm
Eastern Time (ET)
Room 16B
BEH
NEU
DPE
Chair :
Habibeh Khoshbouei
University of Florida
Lynette Daws
University of Texas Health Science Center at San Antonio
Dr. Zahniser pioneered research elaborating our understanding of how dopamine and glutamate contribute to individual differences in cocaine-induced brain plasticity and addiction-like behavior, and how dopamine transporters are rapidly regulated. Her findings underscore the overall importance of dopamine transporters in contributing to enhanced vulnerability to cocaine addiction and relapse. Dr. Zahniser was strongly committed to mentoring young scientists, and to ASPET. In tribute of her many accomplishments, this symposium captures the most recent advances in understanding dopamine transporter function and regulation, and its important role in health, disease, and addiction. Importantly, this symposium highlights novel targets for treating dopamine-linked pathologies.
Speakers
Susan Amara
- NIMH
Dopamine Transporters and Psychostimulant Action: Lessons from Nancy
Aurelio Galli
- University of Alabama-Birmingham
Dopamine Transporters: Linking Obesity to Diabetes to Psychiatric Disorders
Phillip Mackie
- University of Florida
Altered Dopamine Transporter Function and Immunoregulation in PD Macrophages
Felix Mayer
- Institute of Pharmacology, Medical University of Vienna
An Unsuspected Role for Organic Cation Transporter 3 in the Actions of Amphetamine
Lynette Daws
- University of Texas Health Science Center at San Antonio
DATS Not All: Organic Cation Transporters in the Actions of Psychoactive Drugs
Margaret Gnegy
- University of Michigan
Modulation of Stimulant Actions by the Intertwining Activities of D2 Autoreceptors and PKCbeta
Ulrik Gether
- University of Copenhagen
Moving from Neuronal Transporter Structures to Clinically Relevant Therapeutics for Neurodegenerative Disorders